Sequent Specialty Chemicals Profile
Key Indicators
- Authorised Capital ₹ 8.00 Cr
as on 16-01-2025
- Paid Up Capital ₹ 7.92 Cr
as on 16-01-2025
- Company Age 15 Year, 3 Months
- Last Filing with ROC 31 Mar 2016
- Revenue %
(FY 2016)
- Profit 98.30%
(FY 2016)
- Ebitda 98.31%
(FY 2016)
- Net Worth -35.97%
(FY 2016)
- Total Assets 0.30%
(FY 2016)
About Sequent Specialty Chemicals
- CIN/LLPIN
U24230KA2009PTC051060
- Company No.
051060
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Oct 2009
- Date of AGM
30 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sequent Specialty Chemicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramaprasad Sriraman  | Director | 01-Oct-2009 | Current |
| Shridhara Kela | Director | 04-Jun-2012 | Current |
Financial Performance of Sequent Specialty Chemicals.
Sequent Specialty Chemicals Private Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 98.3% increase in profit. The company's net worth observed a substantial decline by a decrease of 35.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sequent Specialty Chemicals?
In 2016, Sequent Specialty Chemicals had a promoter holding of 0.06% and a public holding of 99.94%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Skanray Healthcare Global Private LimitedActive 11 years 9 monthsRamaprasad Sriraman is a mutual person
- Hydra Active Pharma Sciences Private LimitedActive 8 years 1 month
Ramaprasad Sriraman is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sequent Specialty Chemicals?
Unlock and access historical data on people associated with Sequent Specialty Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sequent Specialty Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sequent Specialty Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
